Lancet Oncology, 1470-2045

Journal

Related Publications
  1. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

    Dinmohamed, A. G., Visser, O., Verhoeven, R. H. A., Louwman, M. W. J., van Nederveen, F. H., Willems, S. M., Merkx, M. A. W., Lemmens, V. E. P. P., Nagtegaal, I. D. & Siesling, S., 30-Apr-2020, In : Lancet Oncology. 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study

    TGCT Study Group, Mastboom, M. J. L., Palmerini, E., Verspoor, F. G. M., Rueten-Budde, A. J., Stacchiotti, S., Staals, E. L., Schaap, G. R., Jutte, P. C., Aston, W., Gelderblom, H., Leithner, A., Dammerer, D., Takeuchi, A., Thio, Q., Niu, X., Wunder, J. S. & van de Sande, M. A. J., Jun-2019, In : Lancet Oncology. 20, 6, p. 877-886 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Improving affordability of new Essential Cancer Medicines

    t'Hoen, E., Meyer, S., Durisch, P., Bannenberg, W., Perehudoff, K., Reed, T. & Barber, M. J., Aug-2019, In : Lancet Oncology. 20, 8, p. 1052-1054 4 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  4. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

    FaMRIsc Study Grp, Saadatmand, S., Geuzinge, H. A., Rutgers, E. J. T., Mann, R. M., van Zuidewijn, D. B. W. D. R., Zonderland, H. M., Tollenaar, R. A. E. M., Lobbes, M. B., Ausems, M. G. E. M., van t'Riet, M., Hooning, M. J., Mares-Engelberts, I., Luiten, E. J. T., Heijnsdijk, E. A. M., Verhoef, C., Karssemeijer, N., Oosterwijk, J. C., Obdeijn, I-M., de Koning, H. J. & Tilanus-Linthorst, M. M. A., Aug-2019, In : Lancet Oncology. 20, 8, p. 1136-1147 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

    Banerji, U., van Herpen, C. M. L., Saura, C., Thistiethwaite, F., Lord, S., Moreno, V., Macpherson, I. R., Boni, V., Rolfo, C., de Vries, E. G. E., Rottey, S., Geenen, J., Eskens, F., Gil-Martin, M., Mommers, E. C., Koper, N. P. & Aftimos, P., Aug-2019, In : Lancet Oncology. 20, 8, p. 1124-1135 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (75) »

ID: 1566534